Skip to main content
. 2023 Oct 13;14(5):e01516-23. doi: 10.1128/mbio.01516-23

TABLE 2.

Trikafta treatment alters metabolic activity in select kinase null mutants b

AFUB no. Putative function % change from vehicle % change from WT
AFUB_012420 Mitogen-activated protein kinase 176.5 139.9
AFUB_053520 Calcium/calmodulin-dependent protein kinase, putative 156.6 118.6
AFUB_017750 Protein kinase, putative 154.8 117.3
AFUB_099170 Protein kinase Yak1, putative 129.1 112.3
AFUB_018600 Protein kinase, putative 105.4 79.9
AFUB_101530 Sensor histidine kinase/response regulator, putative 91.6 79.7
AFUB_098230 Inositol kinase kinase (UvsB), putative 91.0 79.1
AFUB_043130 MAP kinase kinase Ste7 99.4 78.8
AFUB_067080 Putative uncharacterized protein 90.1 78.4
AFUB_055480 Serine/threonine protein kinase, putative 88.2 76.7
AFUB_061120 Protein kinase domain-containing protein 87.9 76.5
AFUB_045550 Calcium/calmodulin-dependent protein kinase, putative 86.6 75.4
AFUB_020650 Two-component osmosensing histidine kinase (Bos1) 85.8 74.7
AFUB_032300 Protein kinase, putative 93.2 73.9
AFUB_071990 N/A a 84.6 73.6
AFUB_063830 Ubiquinone biosynthesis protein, putative 84.0 73.0
AFUB_096660 Putative uncharacterized protein 76.7 66.7
AFUB_040390 Protein kinase domain-containing protein 72.6 63.2
a

N/A, not available.

b

The values in bold were selected for a secondary biomass screen.